Showing results (351-360 of 479) with videos related to

Sort By:
Pageof 48
Pharmaceuticals (Basel, Switzerland)|February 26, 2022
Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian CancerYusuke Kobayashi, Takashi Takeda, Haruko Kunitomi, et al.
The American Journal of Pathology|July 27, 2011
Establishment of a choriocarcinoma model from immortalized normal extravillous trophoblast cells transduced with HRASV12Yusuke Kobayashi, Takatsune Shimizu, Hideaki Naoe, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|December 4, 2012
The origin of stroma surrounding epithelial ovarian cancer cellsTomoko Akahane, Akira Hirasawa, Hiroshi Tsuda, et al.
Oncology Reports|January 8, 2013
New candidate therapeutic agents for endometrial cancer: potential for clinical practice (review)Kiyoko Umene, Kouji Banno, Iori Kisu, et al.
Biomed Research International|May 14, 2014
Application of microRNA in diagnosis and treatment of ovarian cancerKouji Banno, Megumi Yanokura, Miho Iida, et al.
Advanced Materials (Deerfield Beach, Fla.)|January 16, 2022
Star-Polymer-DNA Gels Showing Highly Predictable and Tunable Mechanical ResponsesMasashi Ohira, Takuya Katashima, Mitsuru Naito, et al.
Journal of Human Genetics|October 4, 2013
Polymorphisms in the UGT1A1 gene predict adverse effects of irinotecan in the treatment of gynecologic cancer in Japanese patientsAkira Hirasawa, Takeru Zama, Tomoko Akahane, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|June 1, 2017
A Comparison of Dye Versus Fluorescence Methods for Sentinel Lymph Node Mapping in Endometrial CancerWataru Yamagami, Nobuyuki Susumu, Fumio Kataoka, et al.
Oncology Letters|September 21, 2017
New use of microsatellite instability analysis in endometrial cancerHaruko Kunitomi, Kouji Banno, Megumi Yanokura, et al.
Pageof 48